About Jason M. Uslaner

Dr. Jason Uslaner leads the Merck Neuroscience group at West Point focused on discovering novel symptomatic agents to treat pain, neurological, and psychiatric disorders. He also has responsibility for clinical development, co-chairing multiple clinical programs focused on treatments for CNS disorders, while his group provides scientific support for Merck’s Neuroscience marketed products such as Belsomra. Prior to joining the Neuroscience group, Jason was in charge of setting up Merck’s world-class non-human primate lab supporting various Neuroscience projects. He has published over 60 manuscripts in peer-reviewed journals and book chapters and in his 13 years at Merck has been impactful in the advancement of multiple different mechanisms from discovery to the clinic. Prior to joining Merck, Jason received a B.A. from University of California Berkeley, and completed his Ph.D. and postdoctoral studies at The University of Michigan.